Drug Profile
Timcodar
Alternative Names: Timcodar dimesylate; VX-853Latest Information Update: 27 Jun 2007
Price :
$50
*
At a glance
- Originator Vertex Pharmaceuticals
- Class Antineoplastics; Pyridines; Radiosensitisers
- Mechanism of Action Nerve growth factor stimulants; P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Diabetic neuropathies; Solid tumours